Matthew O'Brien Laramy1, Jamie Robinson2, C J Venkatramani1

  • 1Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., South San Francisco, CA.

Transplantation
|October 8, 2024
PubMed
概括

开发用于器官保存解决方案的新型治疗剂需要明确的战略. 这种方法适应了对器官移植的现有亲肠道药物开发期望,解决了改善结果的监管差距.